Results 161 to 170 of about 296,172 (204)

Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Merzbach S   +7 more
europepmc   +1 more source

Adrenomedullin-RAMP2 System Modulates Inflammation and Tissue Repair in Experimental Autoimmune Uveitis Via T-Cell and M2 Macrophage Regulation. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Matsuda Y   +17 more
europepmc   +1 more source

Azathioprine in the Management of Autoimmune Uveitis [PDF]

open access: yesOcular Immunology and Inflammation, 2008
To evaluate the role of azathioprine as an immunosuppressive for steroid-resistant autoimmune uveitis (AIU).Patients using oral prednisolone for active AIU without clinical response were recruited. A standard protocol of oral prednisolone and azathioprine was used.Twenty-seven patients participated in the study: 3 with anterior uveitis, 1 pars planitis,
Simon R. Taylor
exaly   +6 more sources

Immunotherapeutic Strategies in Autoimmune Uveitis

open access: yesAutoimmunity Reviews, 2014
Autoimmune uveitis is an organ-specific disorder characterized by irreversible lesions to the eye that predominantly affect people in their most productive years and is among the leading causes of visual deficit and blindness. Currently available therapies are effective in the treatment of a wide spectrum of uveitis, but are often associated with ...
Luiz Vicente Rizzo   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Tregs in Autoimmune Uveitis

2021
Uveitis is a chronic disease with relapsing and remitting ocular attack, which requires corticosteroids and systemic immunosuppression to prevent severe vision loss. Classically, uveitis is referred to an autoimmune disease, mediated by pro-inflammatory Th17 cells and immunosuppressive CD4+CD25+FoxP3+ T-regulatory cells (Tregs).
Zhaohao, Huang, Wenli, Li, Wenru, Su
openaire   +2 more sources

Treatment of Autoimmune Uveitis

Annals of the New York Academy of Sciences, 1993
The number of effective drugs for the treatment of autoimmune uveitis has greatly increased over the past 40 years. Many patients previously condemned to blindness can now be successfully treated with new immunosuppressive agents. New targets of the immune system, such as cell adhesion molecules, may offer novel therapeutic approaches for the treatment
S M, Whitcup, R B, Nussenblatt
openaire   +2 more sources

Home - About - Disclaimer - Privacy